Erbb2 Amplification | List of Frontiers open access articles

Original Research

Published on 06 Oct 2022

Molecular and clinicopathological characteristics of ERBB2 gene fusions in 32,131 Chinese patients with solid tumors

in Cancer Molecular Targets and Therapeutics

Yin Guan
Yutong Wang
Hongxia Li
Jing Meng
Xia You
Xiaofeng Zhu
Qin Zhang
Tingting Sun
Chuang Qi
Guangyu An

Frontiers in Oncology

doi 10.3389/fonc.2022.986674

8,390 views
9 citations

Case Report

Published on 18 Mar 2021

Case Report: Efficacy of Pyrotinib in ERBB2 Amplification Pulmonary Adenoid Cystic Carcinoma

in Thoracic Oncology

Zhongben Tang
Feng Lin
Jiarong Xiao
Xiaojun Du
Jian Zhang
Sini Li
Gongshun Tang
Chen Chen
Jian Li

Frontiers in Oncology

doi 10.3389/fonc.2021.605658

3,144 views
6 citations

Original Research

Published on 04 Apr 2019

Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort

in Gastrointestinal Cancers

Jeeyun Lee
Aleksandra Franovic
Yukimasa Shiotsu
Seung Tae Kim
Kyoung-Mee Kim
Kimberly C. Banks
Victoria M. Raymond
Richard B. Lanman

Frontiers in Oncology

doi 10.3389/fonc.2019.00212

15,492 views
21 citations

Original Research

Published on 19 Mar 2021

Clinical Utility of a Cell-Free DNA Assay in Patients With Colorectal Cancer

in Cancer Genetics

Ren-Hao Chan
Peng-Chan Lin
Shang-Hung Chen
Shao-Chieh Lin
Po-Chuan Chen
Bo-Wen Lin
Meng-Ru Shen
Yu-Min Yeh

Frontiers in Oncology

doi 10.3389/fonc.2021.589673

6,230 views
10 citations

Original Research

Published on 28 Sep 2022

Genomic landscape of lung adenocarcinomas in different races

in Cancer Genetics

Huashan Shi
Karan Seegobin
Fei Heng
Kexun Zhou
Ruqin Chen
Hong Qin
Rami Manochakian
Yujie Zhao
Yanyan Lou

Frontiers in Oncology

doi 10.3389/fonc.2022.946625

7,841 views
45 citations

Original Research

Published on 29 May 2017

Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma

in Cancer Genetics

Nicolai Skovbjerg Arildsen
Jenny-Maria Jönsson
Katarina Bartuma
Anna Ebbesson
Sofia Westbom-Fremer
Anna Måsbäck
Susanne Malander
Mef Nilbert
Ingrid A. Hedenfalk

Frontiers in Oncology

doi 10.3389/fonc.2017.00109

6,798 views
22 citations

Original Research

Published on 21 Apr 2021

Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer

in Cancer Genetics

Weikai Xiao
Guochun Zhang
Bo Chen
Xiaoqing Chen
Lingzhu Wen
Jianguo Lai
Xuerui Li
Min Li
Hao Liu
Jing Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.618767

9,147 views
22 citations

Articles

Molecular and clinicopathological characteristics of ERBB2 gene fusions in 32,131 Chinese patients with solid tumors

Case Report: Efficacy of Pyrotinib in ERBB2 Amplification Pulmonary Adenoid Cystic Carcinoma

Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort

Clinical Utility of a Cell-Free DNA Assay in Patients With Colorectal Cancer

Genomic landscape of lung adenocarcinomas in different races

Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma

Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer